This site is intended for healthcare professionals only
LoginRegister
Novartis oral Fabhalta gets USFDA nod for adults with C3 glomerulopathyNovartis oral Fabhalta secures USFDA okay for adults with C3 glomerulopathy
USFDA nod to JnJ Tremfya for Crohns diseaseUSFDA nod to JnJ Tremfya for Crohn's disease
Himachal to develop medical device park independentlyPrioritize healthcare security through balanced tariff measures for medical devices: AiMeD urges...
Aurobindo Pharma recallRecall of Medtronic embolization devices classified as most serious by USFDA
Delhi High CourtHimalaya's Liv.52 Trademark Protected: Delhi HC Fines Liv-333 Maker Rs 30 Lakh for Infringement
Natco Pharma gets 7 USFDA observations for Kothur Pharma DivisionAurobindo Pharma arm gets USFDA EIR for Telangana unit
Syngene acquires biologics site from Emergent BioSolutions arm for USD 36.5 millionSyngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions
CDSCO Panel Clears Ciplas Glycopyrronium-Formoterol Inhaler for Phase IV TrialCipla gets exclusive rights to market ophthalmic drug across 11 countries
Bajaj Healthcare gets CDSCO panel nod for Phase III trials for Cenobamate TabletsBajaj Healthcare gets CDSCO panel nod for Phase III trials for anti-seizure drug
Sanofi Sarclisa approved in EUSanofi to buy Autoimmune Disease treatment from Dren Bio for up to USD 1.9 billion
Marksans Pharma Goa facility gets Australian nod to manufacture pharma formulations for Australian marketsMarksans Pharma Goa facility gets Australian nod to manufacture pharma formulations for Australian...
Pfizer discontinues development of danuglipron for chronic weight managementPfizer to exit Haleon
X